DEGOS DISEASE

Clinical trials for DEGOS DISEASE explained in plain language.

Never miss a new study

Get alerted when new DEGOS DISEASE trials appear

Sign up with your email to follow new studies for DEGOS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a common arthritis drug tame a rare, fatal blood vessel disease?

Disease control Recruiting now

This study tests baricitinib, an FDA-approved drug for other conditions, in 12 adults with Kohlmeier-Degos disease affecting the brain and spine. The goal is to see if the drug can stop new lesions from forming and keep existing ones stable. Participants take baricitinib daily fo…

Matched conditions: DEGOS DISEASE

Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

DEGOS DISEASE

Get alerted when new DEGOS DISEASE trials appear

Could a common arthritis drug tame a rare, fatal blood vessel disease?